REPORT ID 1421

Global Systemic Idiopathic Juvenile Arthritis Treatment Market Research Report 2017

Publish Date
06-Dec-17
Pages
108
Format
Electronic (PDF)

In this report, the global Systemic Idiopathic Juvenile Arthritis Treatment market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Systemic Idiopathic Juvenile Arthritis Treatment in these regions, from 2012 to 2022 (forecast), covering
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
Global Systemic Idiopathic Juvenile Arthritis Treatment market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    Alteogen Inc.
    Bristol-Myers Squibb Company
    Epirus Biopharmaceuticals, Inc.
    Johnson & Johnson
    Momenta Pharmaceuticals, Inc.
    Mycenax Biotech Inc.
    Novartis AG
    Oncobiologics, Inc.
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Adalimumab Biosimilar
    Canakinumab
    Golimumab
    Tocilizumab Biosimilar
    Others
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
    Clinic
    Hospital
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Systemic Idiopathic Juvenile Arthritis Treatment Market Research Report 2017
1 Systemic Idiopathic Juvenile Arthritis Treatment Market Overview
    1.1 Product Overview and Scope of Systemic Idiopathic Juvenile Arthritis Treatment
    1.2 Systemic Idiopathic Juvenile Arthritis Treatment Segment by Type (Product Category)
        1.2.1 Global Systemic Idiopathic Juvenile Arthritis Treatment Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
        1.2.2 Global Systemic Idiopathic Juvenile Arthritis Treatment Production Market Share by Type (Product Category) in 2016
        1.2.3 Adalimumab Biosimilar
        1.2.4 Canakinumab
        1.2.5 Golimumab
        1.2.6 Tocilizumab Biosimilar
        1.2.7 Others
    1.3 Global Systemic Idiopathic Juvenile Arthritis Treatment Segment by Application
        1.3.1 Systemic Idiopathic Juvenile Arthritis Treatment Consumption (Sales) Comparison by Application (2012-2022)
        1.3.2 Clinic
        1.3.3 Hospital
        1.3.4 Others
    1.4 Global Systemic Idiopathic Juvenile Arthritis Treatment Market by Region (2012-2022)
        1.4.1 Global Systemic Idiopathic Juvenile Arthritis Treatment Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
        1.4.2 North America Status and Prospect (2012-2022)
        1.4.3 Europe Status and Prospect (2012-2022)
        1.4.4 China Status and Prospect (2012-2022)
        1.4.5 Japan Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Status and Prospect (2012-2022)
        1.4.7 India Status and Prospect (2012-2022)
    1.5 Global Market Size (Value) of Systemic Idiopathic Juvenile Arthritis Treatment (2012-2022)
        1.5.1 Global Systemic Idiopathic Juvenile Arthritis Treatment Revenue Status and Outlook (2012-2022)
        1.5.2 Global Systemic Idiopathic Juvenile Arthritis Treatment Capacity, Production Status and Outlook (2012-2022)

2 Global Systemic Idiopathic Juvenile Arthritis Treatment Market Competition by Manufacturers
    2.1 Global Systemic Idiopathic Juvenile Arthritis Treatment Capacity, Production and Share by Manufacturers (2012-2017)
        2.1.1 Global Systemic Idiopathic Juvenile Arthritis Treatment Capacity and Share by Manufacturers (2012-2017)
        2.1.2 Global Systemic Idiopathic Juvenile Arthritis Treatment Production and Share by Manufacturers (2012-2017)
    2.2 Global Systemic Idiopathic Juvenile Arthritis Treatment Revenue and Share by Manufacturers (2012-2017)
    2.3 Global Systemic Idiopathic Juvenile Arthritis Treatment Average Price by Manufacturers (2012-2017)
    2.4 Manufacturers Systemic Idiopathic Juvenile Arthritis Treatment Manufacturing Base Distribution, Sales Area and Product Type
    2.5 Systemic Idiopathic Juvenile Arthritis Treatment Market Competitive Situation and Trends
        2.5.1 Systemic Idiopathic Juvenile Arthritis Treatment Market Concentration Rate
        2.5.2 Systemic Idiopathic Juvenile Arthritis Treatment Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Systemic Idiopathic Juvenile Arthritis Treatment Capacity, Production, Revenue (Value) by Region (2012-2017)
    3.1 Global Systemic Idiopathic Juvenile Arthritis Treatment Capacity and Market Share by Region (2012-2017)
    3.2 Global Systemic Idiopathic Juvenile Arthritis Treatment Production and Market Share by Region (2012-2017)
    3.3 Global Systemic Idiopathic Juvenile Arthritis Treatment Revenue (Value) and Market Share by Region (2012-2017)
    3.4 Global Systemic Idiopathic Juvenile Arthritis Treatment Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.5 North America Systemic Idiopathic Juvenile Arthritis Treatment Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.6 Europe Systemic Idiopathic Juvenile Arthritis Treatment Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.7 China Systemic Idiopathic Juvenile Arthritis Treatment Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.8 Japan Systemic Idiopathic Juvenile Arthritis Treatment Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.9 Southeast Asia Systemic Idiopathic Juvenile Arthritis Treatment Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.10 India Systemic Idiopathic Juvenile Arthritis Treatment Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Systemic Idiopathic Juvenile Arthritis Treatment Supply (Production), Consumption, Export, Import by Region (2012-2017)
    4.1 Global Systemic Idiopathic Juvenile Arthritis Treatment Consumption by Region (2012-2017)
    4.2 North America Systemic Idiopathic Juvenile Arthritis Treatment Production, Consumption, Export, Import (2012-2017)
    4.3 Europe Systemic Idiopathic Juvenile Arthritis Treatment Production, Consumption, Export, Import (2012-2017)
    4.4 China Systemic Idiopathic Juvenile Arthritis Treatment Production, Consumption, Export, Import (2012-2017)
    4.5 Japan Systemic Idiopathic Juvenile Arthritis Treatment Production, Consumption, Export, Import (2012-2017)
    4.6 Southeast Asia Systemic Idiopathic Juvenile Arthritis Treatment Production, Consumption, Export, Import (2012-2017)
    4.7 India Systemic Idiopathic Juvenile Arthritis Treatment Production, Consumption, Export, Import (2012-2017)

5 Global Systemic Idiopathic Juvenile Arthritis Treatment Production, Revenue (Value), Price Trend by Type
    5.1 Global Systemic Idiopathic Juvenile Arthritis Treatment Production and Market Share by Type (2012-2017)
    5.2 Global Systemic Idiopathic Juvenile Arthritis Treatment Revenue and Market Share by Type (2012-2017)
    5.3 Global Systemic Idiopathic Juvenile Arthritis Treatment Price by Type (2012-2017)
    5.4 Global Systemic Idiopathic Juvenile Arthritis Treatment Production Growth by Type (2012-2017)

6 Global Systemic Idiopathic Juvenile Arthritis Treatment Market Analysis by Application
    6.1 Global Systemic Idiopathic Juvenile Arthritis Treatment Consumption and Market Share by Application (2012-2017)
    6.2 Global Systemic Idiopathic Juvenile Arthritis Treatment Consumption Growth Rate by Application (2012-2017)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Applications
        6.3.2 Emerging Markets/Countries

7 Global Systemic Idiopathic Juvenile Arthritis Treatment Manufacturers Profiles/Analysis
    7.1 Alteogen Inc.
        7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.1.2 Systemic Idiopathic Juvenile Arthritis Treatment Product Category, Application and Specification
            7.1.2.1 Product A
            7.1.2.2 Product B
        7.1.3 Alteogen Inc. Systemic Idiopathic Juvenile Arthritis Treatment Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.1.4 Main Business/Business Overview
    7.2 Bristol-Myers Squibb Company
        7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.2.2 Systemic Idiopathic Juvenile Arthritis Treatment Product Category, Application and Specification
            7.2.2.1 Product A
            7.2.2.2 Product B
        7.2.3 Bristol-Myers Squibb Company Systemic Idiopathic Juvenile Arthritis Treatment Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.2.4 Main Business/Business Overview
    7.3 Epirus Biopharmaceuticals, Inc.
        7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.3.2 Systemic Idiopathic Juvenile Arthritis Treatment Product Category, Application and Specification
            7.3.2.1 Product A
            7.3.2.2 Product B
        7.3.3 Epirus Biopharmaceuticals, Inc. Systemic Idiopathic Juvenile Arthritis Treatment Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.3.4 Main Business/Business Overview
    7.4 Johnson & Johnson
        7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.4.2 Systemic Idiopathic Juvenile Arthritis Treatment Product Category, Application and Specification
            7.4.2.1 Product A
            7.4.2.2 Product B
        7.4.3 Johnson & Johnson Systemic Idiopathic Juvenile Arthritis Treatment Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.4.4 Main Business/Business Overview
    7.5 Momenta Pharmaceuticals, Inc.
        7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.5.2 Systemic Idiopathic Juvenile Arthritis Treatment Product Category, Application and Specification
            7.5.2.1 Product A
            7.5.2.2 Product B
        7.5.3 Momenta Pharmaceuticals, Inc. Systemic Idiopathic Juvenile Arthritis Treatment Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.5.4 Main Business/Business Overview
    7.6 Mycenax Biotech Inc.
        7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.6.2 Systemic Idiopathic Juvenile Arthritis Treatment Product Category, Application and Specification
            7.6.2.1 Product A
            7.6.2.2 Product B
        7.6.3 Mycenax Biotech Inc. Systemic Idiopathic Juvenile Arthritis Treatment Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.6.4 Main Business/Business Overview
    7.7 Novartis AG
        7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.7.2 Systemic Idiopathic Juvenile Arthritis Treatment Product Category, Application and Specification
            7.7.2.1 Product A
            7.7.2.2 Product B
        7.7.3 Novartis AG Systemic Idiopathic Juvenile Arthritis Treatment Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.7.4 Main Business/Business Overview
    7.8 Oncobiologics, Inc.
        7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.8.2 Systemic Idiopathic Juvenile Arthritis Treatment Product Category, Application and Specification
            7.8.2.1 Product A
            7.8.2.2 Product B
        7.8.3 Oncobiologics, Inc. Systemic Idiopathic Juvenile Arthritis Treatment Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.8.4 Main Business/Business Overview

8 Systemic Idiopathic Juvenile Arthritis Treatment Manufacturing Cost Analysis
    8.1 Systemic Idiopathic Juvenile Arthritis Treatment Key Raw Materials Analysis
       8.1.1 Key Raw Materials
       8.1.2 Price Trend of Key Raw Materials
       8.1.3 Key Suppliers of Raw Materials
       8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
       8.2.1 Raw Materials
       8.2.2 Labor Cost
       8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of Systemic Idiopathic Juvenile Arthritis Treatment

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 Systemic Idiopathic Juvenile Arthritis Treatment Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of Systemic Idiopathic Juvenile Arthritis Treatment Major Manufacturers in 2015
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 Global Systemic Idiopathic Juvenile Arthritis Treatment Market Forecast (2017-2022)
    12.1 Global Systemic Idiopathic Juvenile Arthritis Treatment Capacity, Production, Revenue Forecast (2017-2022)
        12.1.1 Global Systemic Idiopathic Juvenile Arthritis Treatment Capacity, Production and Growth Rate Forecast (2017-2022)
        12.1.2 Global Systemic Idiopathic Juvenile Arthritis Treatment Revenue and Growth Rate Forecast (2017-2022)
        12.1.3 Global Systemic Idiopathic Juvenile Arthritis Treatment Price and Trend Forecast (2017-2022)
    12.2 Global Systemic Idiopathic Juvenile Arthritis Treatment Production, Consumption , Import and Export Forecast by Region (2017-2022)
        12.2.1 North America Systemic Idiopathic Juvenile Arthritis Treatment Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.2 Europe Systemic Idiopathic Juvenile Arthritis Treatment Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.3 China Systemic Idiopathic Juvenile Arthritis Treatment Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.4 Japan Systemic Idiopathic Juvenile Arthritis Treatment Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.5 Southeast Asia Systemic Idiopathic Juvenile Arthritis Treatment Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.6 India Systemic Idiopathic Juvenile Arthritis Treatment Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
    12.3 Global Systemic Idiopathic Juvenile Arthritis Treatment Production, Revenue and Price Forecast by Type (2017-2022)
    12.4 Global Systemic Idiopathic Juvenile Arthritis Treatment Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology/Research Approach
        14.1.1 Research Programs/Design
        14.1.2 Market Size Estimation
        14.1.3 Market Breakdown and Data Triangulation
    14.2 Data Source
        14.2.1 Secondary Sources
        14.2.2 Primary Sources
    14.3 Disclaimer